Actively Recruiting
Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome
Led by Taipei Veterans General Hospital, Taiwan · Updated on 2025-01-17
220
Participants Needed
1
Research Sites
102 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
By analyzing the differential proteins in exosomes, this study aims to understand the pathological mechanisms of SJS and DES, identify potential diagnostic and therapeutic methods, and advance the diagnosis and treatment of these diseases.
CONDITIONS
Official Title
Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged between 20 and 75 years
- For Dry Eye Syndrome: Schirmer's test less than 10 mm/5 min
- For Sjogren's Syndrome: primary or secondary diagnosis fulfilling the 2002 American-European Consensus Criteria
- No abnormal immune, liver, kidney, or blood function evaluations for Sjogren's Syndrome
- For healthy controls: aged between 20 and 75 years without any chronic disease
You will not qualify if you...
- Pregnancy or breastfeeding
- Eye inflammation or infectious eye disease
- History of eye surgery
- History of alcohol abuse
- Diabetes mellitus
- Major life-threatening conditions
- Steroid pulse therapy within three months before study start
- For healthy controls: any diagnosis of Sjogren's Syndrome or Dry Eye Syndrome
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ching-Mao
Taipei, Taiwan, Taiwan, 886
Actively Recruiting
Research Team
C
Ching-Mao Chang, M.D., Ph.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
6
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here